← back to search

Neeraj Dhaun

Inserm · FR
Area of research
Nephrology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Vasculitis and related conditions, Blood Pressure and Hypertension Studies, Nitric Oxide and Endothelin Effects, and Renal Diseases and Glomerulopathies.
h-index
46
citations
8,453
works
370
NIH funding
primary concept
email

Recent publications

Endothelin receptor antagonists in chronic kidney disease
Nature Reviews Nephrology 2024cited by 36position: middledoi
Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study
European Heart Journal 2024cited by 11position: lastdoi
Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment
Nature Communications 2023cited by 31position: lastdoi
Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial
The Lancet Rheumatology 2022cited by 36position: middledoi
Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease
Current Opinion in Nephrology & Hypertension 2021cited by 44position: middledoi
Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment
JAMA Internal Medicine 2021cited by 19position: middledoi
Infective Endocarditis Hospitalizations and Outcomes in Patients With End‐Stage Kidney Disease: A Nationwide Data‐Linkage Study
Journal of the American Heart Association 2021cited by 11position: lastdoi
Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland
QJM 2018cited by 0position: middledoi
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I
Journal of Hypertension 2017cited by 32position: middledoi
Hypertension and Its Complications in a Young Man With Autoimmune Disease
Hypertension 2017cited by 3position: lastdoi
Endothelin
Pharmacological Reviews 2016cited by 748position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David J. Webb · Western General Hospital4 papers (2016–2023)Peter J. Gallacher · University of Edinburgh3 papers (2021–2024)Donald E. Kohan · University of Utah3 papers (2016–2024)Nicholas L. Mills · Edinburgh Royal Infirmary2 papers (2021–2024)Hiddo J.L. Heerspink · Kidney Associates2 papers (2021–2024) · 2 papers (2021–2024)Anoop Shah · Rutgers, The State University of New Jersey2 papers (2021–2024)Emily Godden · University of Edinburgh1 papers (2023–2023)Matthew A. Bailey · University of Edinburgh1 papers (2023–2023)Nicholas L. Cruden · Edinburgh Royal Infirmary1 papers (2021–2021)Anton H. van den Meiracker · Roswell Park Comprehensive Cancer Center1 papers (2017–2017)Eva‐Maria Bachmair · University of Glasgow1 papers (2022–2022)David L. Yeung · Amgen (United States)1 papers (2024–2024)Suzanne Oparil · University of Alabama at Birmingham1 papers (2017–2017)Cheryl L. Laffer · Vanderbilt University Medical Center1 papers (2017–2017)Craig Balmforth · University of Edinburgh1 papers (2023–2023)Jennifer S. Pollock · University of Alabama at Birmingham1 papers (2016–2016)Graeme MacLennan · London School of Hygiene & Tropical Medicine1 papers (2022–2022)Gabriel C. Oniscu · Karolinska Institutet1 papers (2023–2023) · 1 papers (2017–2017)